Immuno-Oncology Biotech Company, focusing on developing cutting-edge Immunotherapy treatments for Cancer using Innovative Antibodies and Next Generation Antibody Technologies, particularly in Solid Tumor and Lymphoma Indications.
Founded by leading scientists in the field of Innate Immunity and European Immunology researchers.
Headquartered in Marseille, France and later opened an additional U.S. Office in Rockville, Maryland.
Trading on both Euronext Paris and NASDAQ in the U.S. as a clinical stage Biotech company.
Partnered with Sanofi, AstraZeneca and other Academic Institutions.
Progressively advanced ANKET platform and pipeline products (IPH4502 – Nectin-4 ADC and Lacutamab) to clinical trials.
No AI focus; specializes in biotechnology platforms for innate immunity, antibody engineering, and immuno-oncology therapeutics
Inferred from company descriptions; not AI/protein engineering per query category
| Service | Cost | Details | Source |
|---|---|---|---|
| Limited Early Adopter Access | Custom quote | HCP Engagement Agent with opinion extraction, sentiment analysis, content creation, and actionable insights. Register for personalized walkthrough. | innate-ai.com |
| Feature | Innate AI | Unlikely Competitor 1 | Unlikely Competitor 2 | Unlikely Competitor 3 |
|---|---|---|---|---|
| Core functionality | Gen-AI for Medical Affairs - HCP engagement, insight extraction | |||
| Pricing (starting price) | Custom quote (early adopter) | |||
| Free tier availability | No | |||
| Enterprise features (SSO, audit logs) | Compliance-focused for pharma regulations | |||
| API availability | Integration into CRM/Comms workflows | |||
| Integration count | Scientific literature, clinical trials, KOL insights, social media | |||
| Support options | Personalized walkthroughs for early adopters | |||
| Security certifications | Adherence to AI regulations, explainable AI |
Innate specializes in pharma Medical Affairs with validated knowledge repositories using medical ontologies (MeSH, UMLS, SNOMED-CT); general platforms lack domain-specific validation and compliance for healthcare.
Innate for regulated pharma environments requiring verifiable AI; general platforms for non-regulated use cases.
Traditional CRMs lack autonomous AI agents for real-time HCP sentiment analysis and insight generation; Innate provides specialized Gen-AI for immediate strategic insights.
Innate augments Medical Affairs teams; standard CRMs for basic contact management.
Most analytics platforms require manual data processing; Innate offers autonomous agents with content creation and workflow integration for faster decision-making.
Innate for AI-driven Medical Affairs acceleration; traditional analytics for historical reporting.
AI models generate compatible amino acid sequences from 3D structures by means of extensive sampling of the conformational space.
Transformer-based architectures have been adapted for predicting sequence based upon structural design targets.
Utilizes RF-diffusion-like approaches to generate new proteins with structural constraints.
Employs machine learning techniques to predict alpha-helix, beta-sheet percentages, and amino acid levels.
Incorporates evolutionary constraints to enable multi-mutation predictions that do not result in the loss of epistatic relationships.
The AiCE framework integrates structural and evolutionary constraints into a general model.
| Data Modality | Input Format | Required/Optional | Integration Depth |
|---|---|---|---|
| Protein 3D Structures | PDB files, AlphaFold predictions, structural constraints | Required | Core input for inverse folding generation |
| Protein Sequences | FASTA, UniProt IDs, sequence alignments | Required | Training data and evolutionary constraint extraction |
| Deep Mutational Scanning Data | 60+ DMS datasets, fitness landscapes | Optional | Benchmarking and validation reference |
| Functional Fitness Labels | Activity measurements, binding affinities | Optional | Supervised prediction enhancement |
| Evolutionary Data | Multiple sequence alignments, coupling analysis | Optional | Epistasis modeling and multi-mutation design |
| Complex Structure Data | Protein-nucleic acid interfaces, multi-state structures | Optional | Specialized complex protein engineering |
Enables existing AI models to be unlocked, without requiring re-training.
Offers AiCE modules for seamlessly adding structural and/or evolutionary constraints to existing models.
Offers single and multi-mutation modules for rapidly accelerating design cycles.
Supports compatibility of 60 DMS datasets to ensure performance assurance.
Performs inverse folding with 3D structure input and constraint.
Integrate base editor engineering workflows
